IndraLab

Statements



reach
"shRNA resistant wild-type USP1, but neither USP1 C90S nor USP1Delta260-300, restored cell proliferation, indicating that both USP1 catalytic activity and ID substrate recognition are required to maint[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"The above results suggested that USP1 overexpression, but not USP1 C90S overexpression, promotes bladder cancer cell proliferation, migration, and invasion."